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Background: The high global burden of asthma and tobacco smoking among 
Indigenous people may potentially be reduced by appropriate interventions that target 
prevention of tobacco smoke uptake and improved asthma management. The latter 
includes targeted treatment based on airway inflammation. We undertook a feasibility 
study in two Darwin schools with a high proportion of Indigenous youth to determine 
the feasibility of an innovative, peer-led, school-based education program called the 
Asthma and Smoking Prevention Project (ASPP). A subset of children with reported 
persistent respiratory symptoms were also clinically evaluated to determine the lower 
airway inflammatory profile and optimize asthma management.
Methods: The ASPP is founded on an evidence-based three-step program and targets 
improving asthma management and preventing the uptake of tobacco smoking. The 
program uses a student-centered approach in which senior students (peer leaders) 
deliver the ASPP to Grade 7 students using activities, videos, and games. Students 
completed questionnaires related to asthma and smoking at baseline and 3  months 
after program delivery. Students with respiratory symptoms at 3 months were invited for 
a comprehensive clinical evaluation and tests including sputum induction.
results: The ASPP was well received. Of the 203 students involved, 56 (28%) were 
Indigenous and 70% completed baseline and follow-up questionnaires. Self-reported 
asthma was high (19%), 10% of students reported smoking and 63% reported expo-
sure to tobacco at home. Of the 22 students who were clinically evaluated, 41% were 
Indigenous. Clinically important airway inflammation was high; 23% had Fractional 
Exhaled Nitric Oxide Levels ≥35 ppb, 88% had airway neutrophilia (>15%), and 29% 
had airway eosinophilia (>2.5%). Optimization of medication and management was 
required in 59% of students.
Abbreviations: ASPP, Asthma and Smoking Prevention Project; ACT, Asthma Control Test; eCO, exhaled carbon monoxide 
test; CO, carbon monoxide in breath; IQR, interquartile range; NT, Northern Territory; QoL, quality of life; Triple A, adolescent 
asthma action.
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inTrODUcTiOn
Respiratory health is poorer in Indigenous populations globally 
(compared to their non-Indigenous counterparts) including in 
Australia (1). Asthma and tobacco smoking are arguably the most 
important public health issues of all the respiratory health prob-
lems relevant to Indigenous populations (2, 3). Tobacco smoking 
is a major risk factor for adverse asthma-related outcomes (4). 
Further, despite declining rates of daily smoking in Australia 
(5), the prevalence of smoking among Indigenous people, with 
and without asthma remains disproportionately higher than 
other Australians (2). The prevalence of asthma is also higher in 
Indigenous Australians (17.5%) compared with non-Indigenous 
Australians (10.1%) (6), with poorer asthma outcomes more 
likely in Indigenous Australians (e.g., they are three times more 
likely to die from asthma) (7). However, both these respiratory 
health problems (tobacco smoking and asthma outcomes) can be 
improved by targeted effective programs that are culture specific 
(8, 9).
The various effective programs for tobacco control include 
legal, community, and individual approaches (10, 11). At the 
individual level, preventing the uptake of tobacco smoking is 
arguably superior to methods for quitting smoking as smoking 
behaviors are often established in youth and are a strong predictor 
of later daily smoking and poorer long-term outcomes (12, 13). 
In Australia, more than two-thirds of Indigenous smokers and 
ex-smokers began smoking regularly before the age of 18 years 
(6). Thus, to tackle the high prevalence of tobacco smoking in 
at-risk groups such as Indigenous people, prevention strategies 
in adolescence is important and needed.
However, there are few preventative programs targeting 
at-risk groups such as Indigenous populations (14). In non-
Indigenous settings, current evidence suggests that school-
based smoking prevention programs can have substantial 
positive effects in both the short and long term (11). Schools 
are an ideal place for initiating health promotion programs as 
they provide easy access to the target group and complement 
health and well-being. They also encourage young people to 
assume leadership roles and take responsibility for their health. 
Peer-led education also provides a unique opportunity to dis-
seminate hard to deliver messages. At this age, peers have a 
greater influence on health behaviors than do parents or health 
personnel (15).
A peer-led program, the “Adolescent Asthma Action 
Program” (Triple A), was developed as a response to concerns 
about high rates of asthma attacks, school absenteeism and 
smoking in schools (15). Triple A was efficacious in non-Indig-
enous settings in Australia (16) and Jordan (17), but has not 
been available in schools with at-risk groups such as Indigenous 
youth. We, therefore, conducted a feasibility study based on the 
Triple A program (15, 16) with an added smoking prevention 
module, called the “Asthma and Smoking Prevention Project” 
(ASPP).
Other strategies to improving respiratory health (e.g., asthma 
outcomes) include targeted therapies based on airway inflamma-
tion (18). Non-eosinophilic airway inflammation, measured by 
sputum cellularity (19), is an important cause of severe asthma (20) 
and is associated with smoking (21). While eosinophilic asthma 
responds to corticosteroids, non-eosinophilic asthma has a poor 
response to corticosteroids and is related to increased asthma 
severity (22). An important association with non-eosinophilic 
airway inflammation includes systemic inflammatory markers 
(e.g., C-reactive protein and interleukin-6) (23). These drivers 
of inflammation are modifiable (23) and have the potential to 
improve detection and management of respiratory health. None 
of these factors, however, have been examined in adolescents with 
persistent respiratory symptoms.
Thus, in our feasibility study, our primary aim was to deter-
mine whether the ASPP was acceptable and relevant for schools 
in Northern Territory (NT) schools with high proportion of 
Indigenous students. Our secondary aim was to clinically evalu-
ate a subset of students with self-reported respiratory symptoms 
to (i) examine the type of lower airway inflammation profile and 
(ii) optimize asthma management.
MaTerials anD MeThODs
study Design and setting
We conducted this feasibility study (during March to June 2014) 
in two schools with a high number of Indigenous students in 
Darwin, the capital of the NT of Australia. A third school with 
more than 170 Grade 7 students withdrew prior to implement-
ing ASPP due to logistical issues at the school level unrelated to 
the study. One school was a middle school (Grades 7–9) and the 
second a high school (Grade 7–12). This study was approved by 
the local Human Research Ethics Committee (HREC-2012-1900) 
and the NT Department of Education and Children’s Services 
(DET2013/138). One school used the opt-out format for consent, 
whereas the second requested the opt-in approach where writ-
ten informed consent was obtained from caregivers. Indigenous 
ethnicity was self-reported (Aboriginal and/or Torres Strait 
conclusion: Our study has demonstrated the implementation of the ASPP was well 
received by the schools as well as by the students. The high prevalence of clinically 
important airway inflammation and suboptimal asthma management highlights the need 
for a community-based study on persistent respiratory symptoms in adolescents to 
reduce the burden of chronic lung disease particularly for Indigenous Australians.
Keywords: asthma, adolescent, indigenous, airway inflammation, tobacco smoking, school-based service
FigUre 1 | asthma and smoking Prevention Project flow diagram.
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Islander). Participants in our study were minors, thus consent 
was required to be obtained from caregivers.
implementation of the asPP
High-level negotiation was undertaken with the NT Department 
of Education and Children’s Services to support the implementa-
tion of the ASPP into the nominated schools, and with school 
principals to embed the ASPP into the Health and Physical 
Education curriculum. The principals also identified key teachers 
to help drive the implementation into Grade 7 classes. ASPP staff 
presented the program to key teaching staff prior to roll out of 
the ASPP.
Participants
The ASPP participants consisted of two groups (i) Peer Leaders 
(15–17 years) and (ii) Grade 7 (12–14 years) students (the target 
intervention group). Peer Leaders were students in either Grade 
9 or 11 (depending which school they attended). The number of 
Peer Leaders was dependent on the size of the school. Selection 
of Peer Leaders was undertaken by teachers, based on assessment 
of student leadership qualities. All Grade 7 students completed 
the program, but the exhaled carbon monoxide (eCO) test and 
questionnaires were obtained only in those with a completed 
consent form.
Details of the asPP
We briefly describe the Triple A (15, 16) methods as they have 
previously been published (15, 17, 24). The ASPP is based on 
the Triple A program (15, 16) enriched with experience from 
existing tobacco education programs for Indigenous Australians, 
including normative education, training and social consequences 
of smoking, parental influences, and self-efficacy to resist smok-
ing (25). The ASPP uses a student-centered strength-based 
approach to increase knowledge of asthma at a school level, 
create a supportive environment for students with asthma, and 
to promote a non-smoking culture in schools.
The theoretical basis of ASPP is embedded in social cognitive 
theory (15), which proposes a reciprocal interaction between a 
person, a targeted behavior, and a particular social context. It 
emphasizes that people learn not only from their own experi-
ences but also by observing the actions of others. Adolescents 
are encouraged to (i) observe and imitate the positive behaviors 
of others, (ii) see positive behaviors modeled and practiced, (iii) 
empower and increase their own capability and confidence to 
implement new skills, (iv) adopt positive attitudes about imple-
menting new skills, and (v) experience a supportive environment 
in order to use their new skills. The ASPP has been shown to 
encourage a sense of personal responsibility and improved qual-
ity of life for students with asthma, with fewer asthma attacks and 
reduced school absenteeism (17).
Educator Workshop and Steps of the ASPP
Before implementation of the ASPP in schools, educators were 
trained in an interactive 1-day workshop using standardized pro-
gram manuals. The educators included Asthma Foundation NT 
staff, school nurses, university students (e.g., pharmacy students) 
(26), and research nurses. Following the educators’ workshop, the 
school component was undertaken and consisted of three steps 
(Figure 1) (16).
Step 1
Involved the ASPP educators’ training volunteer students were 
involved as peer leaders in an interactive 1-day workshop. The 
process was based on empowerment education, using a variety of 
strategies (e.g., videos, games, role plays, and quiz shows) during 
school lessons. Peer leaders learnt about asthma and smoking 
refusal skills and strategies to lead and teach their younger peers 
using standardized program manuals, detailed lesson plans, and 
materials (15).
TaBle 1 | school demographics of participating students.
school 1 school 2 Total
n = 130 (%) n = 73 (%) n = 203 (%)
Male/female 61/69 30/43 91/112
Indigenous 19 (15) 37 (51) 56 (28)
Number of Grade 7s 93 (72) 66 (90) 159 (78)
Number of peer leaders 37 (28) 7 (10) 44 (22)
Completed baseline questionnairea 108 (83) 68 (93) 176 (87)
Completed follow-up questionnaireb 107 (82) 49 (67) 156 (77)
Completed both questionnaires 98 (75) 44 (60) 142 (70)
an = 27 did not complete questionnaire.
bn = 47 did not complete questionnaire.
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Step 2
The peer leaders worked in groups of four (with support from 
class teachers) and delivered the four lessons of the ASPP to 
Grade 7 classes (target group) using standardized program 
manuals and materials (15). Sessions focused on asthma 
(how to avoid triggers, prevent exercise induced asthma, 
and what to do during an asthma attack) and peer pressure 
resistance training (e.g., how to say “no” to smoking; taking a 
smoke-free pledge). Learning was through videos, interactive 
games, and quiz shows, while furthering their skills in group 
leadership (15).
Step 3
The Grade 7 students disseminated what they had learnt in the 
ASPP to members of the school community and family through 
creative performances, e.g., drama, dance, and rap activities.
Data collection
At baseline (before the ASPP was delivered), students (who 
consented) undertook an eCO test and questionnaire. The eCO 
test was done using the PiCO+ Smokerlyzer® device [Bedfont 
Scientific, England, UK measuring in parts per million (ppm)]. 
In our study, the cut off point for adolescent smokers was defined 
as elevated levels of carbon monoxide in breath (CO) >4 ppm 
(27). Student questionnaires included: the International Study 
of Asthma and Allergies in Childhood Questionnaire (28) with 
modified questions for chronic respiratory disease from the St. 
George’s Respiratory Questionnaire, questions on cough (29), the 
asthma control test (ACT) was a composite score (ranging from 
0 to 12) and smoking-related questions. eCO and questionnaires 
were repeated at the 3-month follow-up.
At the end of their workshop, Peer Leaders completed a 
feedback questionnaire. Teaching staff also provided informal 
feedback about the ASPP.
clinical evaluation
Students reporting current respiratory symptoms or self-reported 
asthma on the 3-month follow-up questionnaire were invited to 
have a clinical evaluation by a respiratory specialist. Demographic, 
medical history, and clinical data were recorded on standardized 
data collection forms for students whose caregiver provided writ-
ten consent.
Participants were clinically evaluated and undertook addi-
tional tests: Fractional Exhaled Nitric Oxide (FENO) using the 
Niox Mino (Aerocrine, Sweden) (30), spirometry (easy on-PC, 
ndd, Zurich, Switzerland), airway hyper-responsiveness (AHR) 
using hypertonic saline and sputum induction. The standard-
ized 4.5% hypertonic saline challenge was used and sputum was 
processed using standard methods as previously done and (31) 
venipuncture (for full blood count and C-reactive protein) was 
also undertaken in those who had provided consent.
Definitions
An AHR positive result was defined as a fall in forced expiratory 
volume during the first second (FEV1) of ≥15% from baseline 
(31). FeNO values ≥35  ppb (30) were considered abnormal. 
Airway eosinophilia and neutrophilia were considered present 
when the percentage of sputum eosinophils and neutrophilia 
were >3 and >15%, respectively (32, 33). Optimization of 
clinical management and classification of asthma was in accord-
ance with the Australian Asthma Handbook. Management and 
classification for cough was based on an evidence-based cough 
guideline (34).
analyses
Data were entered on an Access database and analyzed using 
Stata version 14 (StataCorp, College Station, TX, USA). Data are 
presented as numbers and percentages, median and interquartile 
range (IQR) 25–75%, mean and SD or range, depending on data 
distribution. As this was a feasibility pilot study, before and after 
statistical comparison and a sample size calculation were not 
undertaken. However, we aimed to recruit 200 Grade 7 students 
as our target group. Qualitative data from Peer Leaders were 
thematically described.
resUlTs
schools/Demographics
Of the total number of Grade 7s (School 1: n = 190 and School 
2: n = 77), consent was obtained from 49% from School 1 and 
98% from School 2. A total of 203 students from the two schools 
participated in this study (e.g., completed questionnaires and 
eCO). The number of participating students per school is sum-
marized in Table 1. Over half the students were female (55%) and 
56 (28%) were Indigenous. Due to small numbers in this study, 
data were combined and results presented as a total.
Questionnaires
Questionnaires were completed by 173 students at baseline and 
a further 156 at 3  months. Students completed baseline ques-
tionnaires unsupervised. As these were poorly completed (e.g., 
inconsistent and incomplete answers), ASPP staff supervised 
the completion of the follow-up questionnaires at 3  months 
(ASPP staff were in the classroom and helped when requested). 
At baseline, self-reported asthma was high (n = 33, 19%) with 
20% of students reporting wheezing in the previous 12 months. 
Previous smoking was reported in 18 (10%) students, with first 
time smoking in 14 (8%) students aged less than 12 years. More 
than 24% reported that their friends were current smokers. 
TaBle 2 | Baseline and follow-up questionnaire results.d
Baseline Follow-up
n = 176 n = 156
isaac questionnaire
Wheezing in last 12 months 36 (20%) 34 (22%)
Wheezing during exercise in the last 12 months 41 (23%) 34 (22%)
Ever diagnosed with asthma by doctor 33 (19%) 21 (13%)
asthma control test (acT)a
ACT score (0–12)b 9 (6–10) 9 (7–9)
cough
Any cough present 56 (32%) 30 (19%)
Acute cough (≤14 days) 32 (18%) 20 (13%)
Chronic cough (≥28 days) 11 (6%) 7 (4.5%)
smoking questions
Number of students ever tried smoking? 18 (10%) 15 (10%)
How old when tried smoking
≤12 years 14 (8%) 13 (8%)
>12 years 7 (4%) 5 (3%)
Family/household smoking
How many people smoke cigarettes at home? (range) 1–20 1–15
Who smokes in your family?
Mum 48 (27%) 46 (29%)
Dad 63 (36%) 51 (33%)
Siblings (brother/sister) 31 (18%) 22 (14%)
Aunt/uncle(s) 33 (19%) 25 (16%)
Grandparent(s) 28 (16%) 24 (15%)
Other 24 (14%) 21 (13%)
are there rule about smoking cigarettes at home?c
No rules 27 (15%) 22 (14%)
No one is allowed to smoke in my home 62 (35%) 60 (38%)
Only special guests are allowed to smoke in my home 7 (4%) 2 (1%)
People are allowed to smoke in certain areas in my 
home
9 (5%) 16 (10%)
People are allowed to smoke anywhere in my home 7 (4%) 2 (1%)
People are allowed to smoke outside only 86 (49%) 75 (48%)
Baseline Follow-up
n = 176 n = 156
smoking and friends
how many of your closest friends smoke?
None 102 (58%) 88 (56%)
1 or 2 24 (14%) 25 (16%)
3 or more 19 (11%) 14 (9%)
Unsure 19 (11%) 24 (15%)
Would you smoke a cigarette, if friend offered it?
Yes 1 (1%) 2 (1%)
No 160 (91%) 143 (92%)
Maybe 8 (5%) 7 (4.5%)
aOnly students who self-reported asthma on questionnaires.
bInterquartile range (IQR) (25, 75).
cSome responses have more than one answer.
dThe numbers reported in the table do not match up (e.g., response to “ever tried 
smoking” was reported as no and response to “how old when smoking” an age was 
reported). We have, therefore, reported what was transcribed by the students and 
recognized as a limitation as described in the discussion.
Missing data at baseline: wheezing in last 12 months; n = 1 (0.5%), wheezing when 
exercising; n = 1 (1%), doctor confirmed asthma; n = 2 (1%), how bad is asthma 
today; n = 6 (3%), is asthma a problem when exercising; n = 6 (3%), cough because of 
asthma; n = 7 (4%), wake at night because of cough; n = 6 (3%), current cough; n = 6 
(3%), ever tried smoking; n = 6 (3%), age tried smoking; n = 2 (1%), current smokers; 
n = 5 (3%), last cigarette; n = 5 (3%), how often smoke; n = 11 (6%), mum smoke; 
n = 9 (5%), dad smoke; n = 9 (5%), brother/sister smoke; n = 9 (5%), aunt/uncle; n = 9 
(5%), grandparent; n = 9 (5%), other; n = 9 (5%), rules for smoking; n = 14 (8%), no 
smoking at home; n = 15 (9%), guests smoke’ n = 15 (9%), smoke in certain areas; 
n = 15 (9%), smoke anywhere; n = 15 (9%), smoke outside only; n = 15 (9%), friends 
smoke; n = 9 (5%), offered smoke; n = 7 (4%).
Missing data at follow-up: wheezing in last 12 months; n = 1 (1%), wheezing when 
exercising; n = 1 (1%), doctor confirmed asthma; n = 1 (1%), how bad is asthma 
today; n = 1 (1%), is asthma a problem when exercising; n = 1 (1%), cough because of 
asthma; n = 1 (1%), wake at night because of cough; n = 1 (1%), current cough; n = 2 
(2%), ever tried smoking; n = 3 (2%), age tried smoking; n = 1 (1%), current smokers; 
n = 3 (2%), last cigarette; n = 4 (3%), how often smoke; n = 8 (5%), mum smoke; 
n = 6 (4%), dad smoke; n = 6 (5%), brother/sister smoke; n = 6 (4%), aunt/uncle; n = 6 
(4%), grandparent; n = 6 (4%), other; n = 7 (4.5%), rules for smoking; n = 10 (6%), no 
smoking at home; n = 10 (6%), guests smoke’ n = 10 (6%), smoke in certain areas; 
n = 10 (6%), smoke anywhere; n = 10 (6%), smoke outside only; n = 10 (6%), friends 
smoke; n = 5 (3%), offered smoke; n = 4 (3%).
TaBle 2 | continued
(Continued)
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Exposure to tobacco smoke at home was very high, with more 
than 99 (63%) students living in a house with >1 smoker (range 
1–20 smokers). The smoking pledge was signed by 87 (49%) 
students, with 48 (27%) students leaving the question empty. 
Results of baseline and 3-month questionnaires are summarized 
in Table 2.
Of those students who completed both questionnaires 
(n = 142, 70%), results were paired. Fifteen students completed 
the ACT; there was no change in the median ACT score from 
baseline (IQR 8.5, 6–10) to 3 months (IQR 8.5, 7–10). Only three 
students (2%) reported being current smokers at baseline with 
none at follow-up. Students’ exposure to tobacco smokers at 
home was high (range 1–20 smokers).
The eCO test was well received by students and was obtained 
for 91 (45%) students at baseline and 77 (34%) at 3  months. 
At baseline, elevated CO levels were found in three (3%) 
students compared with four (5%) at 3  months. Of the three 
students who reported being current smokers at baseline, only 
one had elevated CO levels consistent with that of a smoker 
(>4 ppm) (27).
Feedback of the asPP
The students’ feedback was overwhelmingly positive, with the 
most common responses described in Table 3. While we did not 
formally evaluate the ASPP for teaching staff, teachers were also 
receptive to the program as described: “I am glad you let us trial 
this at our school. It has been a character building event for a lot of 
the Year 9’s that participated. We have noticed more engagement 
and involvement with other students and many have kept their 
connections to their Year 7 peers too. A great program, we hope you 
will consider us again.” Further, both schools provided support 
for further implementation of the ASPP and have invited us to 
run the program again in the future.
TaBle 3 | Peer leader feedback.
Questions Most common responses
What are the most 
important points gained 
from Asthma and 
Smoking Prevention 
Project?
How important asthma awareness is (9%)
How to treat someone who is having an asthma 
emergency (53%)
How to teach others about asthma (9%)
Asthma can kill you (2%)
Asthma is important and serious (24%)
Smoking makes asthma worse (4%)
Ways to say no to smoking (9%)
Go get check-ups often (2%)
What causes asthma attacks (triggers) and how to deal 
with them (44%)
What happens to your lungs when you have an asthma 
attack (4%)
Asthma won’t prevent you from living your life (4%)
Fun and teamwork (20%)
Gaining confidence to speak in public (20%)
How to say “no” to smoking (4%)
Working together as a team (4%)
What did you like in 
particular?
The fun of the workshop (13%)
Hands on activities/games (42%)
How the presenters did the workshop—it was not 
boring/they had games (11%)
Sit down and talk and then break the day into activities 
(2%)
Role playing (2%)
The videos about asthma (4%)
Doing first aid presentations (6%)
The safe environment for learning (4%)
The straw game—it helped understand what it feels 
like to have asthma (4%)
Learning about smoking (4%)
What can be improved? Nothing (64%)
More standing or more activities outside (7%)
Structure of questionnaires could be improved (2%)
TaBle 4 | Demographic and clinical characteristics of 22 students with 
current respiratory symptoms.
n = 22 (%)
Male/female 4/18
Age (years)a 13 (1.4)
Indigenous 9 (41%)
Gestational age (weeks) 40 (38–41)
Birth weight (kg) 3.2 (2.8, 3.6)
Special care nursery admission 1 (6%)
Previous respiratory hospitalization 3 (14%)
Mother smoked during pregnancy 7 (32%)
Exposed to household smoke 8 (36%)
symptoms
current symptoms
Breathless 6 (27%)
Wheeze 5 (23%)
Hemoptysis 0 (0%)
Chest pain 5 (23%)
Tiredness/lethargy 6 (27%)
ever symptoms
Breathless 15 (68%)
Wheeze 15 (68%)
Hemoptysis 1 (5%)
Chest pain 15 (68%)
Tiredness/lethargy 17 (77%)
clinical examination
Dry/wet cough 19/3
Chest wall hyperinflation 2 (9%)
Wheeze present 1 (5%)
Crackles present 0 (0%)
Chronic suppurative otitis media 1 (5%)
classification of persistent asthma
Mild 6 (27%)
Moderate 2 (9%)
Severe 1 (5%)
(Continued)
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clinical evaluation
Of the 37 students who reported current respiratory symptoms on 
the 3-month questionnaire, consent was obtained for 24 (65%). 
The clinical evaluation took place within 3 weeks of the 3-month 
questionnaire. Two students were away at the time leaving 22 
students who undertook this component. Table 4 provides the 
demographic and clinical characteristics of these students.
Over 20% of students reported current symptoms of breath-
lessness, wheeze, chest pain, and tiredness/lethargy (Table  4). 
Cough was reported in all students, with a dry cough 19 (86%) 
being most common.
Clinical diagnosis of asthma (intermittent or persistent) was 
higher 12 (54%) than student self-reported asthma 10 (46%). 
Eight of the eleven students with known asthma pre-evaluation 
had persistent asthma (Table 4). Optimization of asthma medica-
tions and change of management was required in 59% of students. 
Importantly, one student was suspected to have bronchiectasis 
and was referred for further investigation.
Tests Results
All students completed FENO, spirometry, and AHR challenge. 
Induced sputum was successfully collected from 17 (77%) students. 
Clinically important high FENO levels (≥35 ppb) were documented 
in five (23%) students. Fifteen (88%) students had clinically impor-
tant airway neutrophillia (>15% neutrophils) and 6 (35%) had 
airway eosinophilia (>2.5%). Of the five with FeNO levels ≥35 ppb, 
the median FeNO was 47 (max = 109), three were known to have 
asthma pre-evaluation, and airway eosinophilia was present in one. 
Of the 15 students with airway neutrophilia, five were known to 
have asthma pre-evaluation. Four (18%) students had abnormal 
spirometry results, but AHR was not present in any student.
A blood sample was collected from 14 (64%) students, 
and all results were within the normal ranges for cell counts. 
Absolute counts are as follows: Neutrophils: median 4 (IQR 3, 5); 
Eosinophils: median 0.4 (IQR 0.2, 0.7); and C-reactive protein: 
mean 1.3 (SD 0.7). The median peripheral eosinophil count in 
those with airway eosinophilia was 0.55 (IQR 0.3, 0.7).
DiscUssiOn
Our study involving 203 students from two schools with a high 
percentage of Indigenous students showed that the ASPP was a 
n = 22 (%)
spirometry and FenO (n = 22)
FEV1b 90 (82, 100)
Forced vital capacityb 95 (83, 102)
FENO <20 ppb 13 (59%)
FENO 20–<35 ppb 4 (18%)
FENO ≥35 ppb 5 (23%)
sputum characteristics (n = 17)
Mucoid 3 (18%)
Mucopurulent 1 (6%)
Purulent 2 (12%)
airway inflammation
Eosinophilia (>2.5%) 6 (35%)
Airway neutrophilia (>15%) 15 (88%)
clinical classification and management (n = 22)
Self-identified asthma (on follow-up Q) 10 (46%)
asthma diagnosed at clinical review
Intermittent asthma 4 (18%)
Persistent asthma 8 (36%)
Optimization of medication and change of 
management plans
13 (59%)
aMean (SD).
b% predicted and IQR (25, 75).
n = 1 child away for clinical examination. n = 1 child excluded as did not have medical 
records. Results are for only those children who completed clinical review missing 
(ever breathless, n = 1 (4%), ever wheeze, n = 1 (4%); ever hemoptysis, n = 1 (4%); 
ever tired/lethargic, n = 2 (9%), ever breathless 12 months, n = 2 (9%), ever wheeze 
12 months, n = 2 (9%); ever hemoptysis 12-months, n = 2 (9%); ever chest pain, n = 2 
(9%), ever tired/lethargic 12 months, n = 2 (9%), ever breathless 12 months, n = 2 
(9%), ever wheeze 12 months, n = 2 (9%); ever hemoptysis 12 months, n = 2 (9%); 
ever chest pain, n = 2 (9%), ever tired/lethargic 12 months, n = 2 (9%), breathless now, 
n = 3 (13%), wheeze now, n = 3 (13%); hemoptysis now, n = 3 (13%); chest pain now, 
n = 3(13%), tired/lethargic now, n = 3 (13%), mum smoked(not stated, n = 10 (44%), 
exposed to household smoke, n = 7 (30%), previous respiratory hospitalization, n = 1 
(4%), birth weight, n = 5 (23%), ICU admission, n = 1 (4%). mucoid (n = 13 (59%), 
sputum type; n = 13 (59%).
TaBle 4 | continued
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feasible program for implementation into schools in the NT. For 
the clinical evaluation component, we found that students with 
respiratory symptoms had clinically important airway inflamma-
tion (35% airway eosinophilia and 88% neutrophilia) and clini-
cally important elevated FENO levels (23% with values ≥35 ppb). 
Most students (59%) also required optimization of medication 
and management.
Our feasibility study established that the ASPP was well 
received in the urban NT schools. This was evidenced by (i) 
support from the NT Department of Education, (ii) successful 
implementation of the ASPP within school’s curriculum with 
minimal disruptions to existing curricula, (iii) positive feedback 
from Peer Leaders of the acceptability of the ASPP, (iv) teacher 
endorsement and willingness to be involved in future implemen-
tation of the program, and (v) obtaining a 70% response rate for 
follow-up questionnaires at 3 months. This study illustrates the 
potential for further school-based health interventions in at-risk 
groups.
Previous smoking was reported by 10% of students, with first 
time smoking when aged less than 12 years in 8% of students. 
These data are consistent with anecdotal evidence from several 
remote NT Indigenous communities, reporting that smoking 
is initiated among children aged less than 13 years. Students in 
our study reported high exposure to tobacco smoke at home 
(63%), far exceeding nationally reported data (7.8%) (2). This is 
consistent with our previous study on children hospitalized for 
asthma, which reported high exposure to tobacco smoke at home 
(Indigenous 95.2% and non-Indigenous 45.7%) (35). Our results 
highlight the importance of integrating interventions during 
adolescence to target social norms, behaviors, and attitudes (36) 
to prevent the uptake of tobacco smoking and prevent poorer 
long-term outcomes [e.g., chronic respiratory diseases such as 
bronchiectasis (35) and cardiovascular disease] (37).
Our sample was too small to examine for differences for 
improved asthma control and reduced uptake of tobacco smok-
ing, and our study was not designed to replicate the results 
of previous studies (16, 17). However, we identified several 
important findings, including high self-reported asthma (19%) 
compared to the national average of 10.2% (2). Of those students 
with asthma, more than 20% reported being symptomatic in 
the previous 12 months, which is consistent with data reported 
from the Australian National Young People and Asthma Survey 
(38). Thus, our study that is focused on individuals, confirms the 
need to improve the diagnosis and management of respiratory 
symptoms in this age group.
Of students who underwent clinical evaluation, those with 
asthma had either poorly controlled asthma and/or were incor-
rectly diagnosed with asthma. Although no one had elevated 
systemic inflammatory markers, a majority had clinically 
important airway inflammation [88% had clinically important 
airway neutrophillia (>15%) and 35% had airway eosinophilia 
(>3%) (32, 33)]. Our findings of the lack of systemic makers in 
the presence of clinically important lower airway inflammation 
is in contrast to data in adults but consistent with pediatric 
studies (39, 40). We (41, 42) and others (39, 40) have shown the 
discordance between local (i.e., airways) and systemic inflam-
mation in children with chronic lower airway infection and 
asthma, respectively. The possible reasons for this discordance 
include the lack of spill over effect in children (compared to 
adults) and the cross-sectional study design. However, these 
remain speculative and an in-depth discussion is beyond the 
scope of this paper. The reason for our findings of a very high 
proportion with airway neutrophilia is unknown, but possibly 
related to various factors, including tobacco smoke exposure, 
acute, and/or chronic persistent lower airway infection (1–3). 
Tobacco smoking in people with asthma is a known risk factor 
for poor asthma control and non-eosinophilic airway inflam-
mation (21, 43). Eosinophilic inflammation identified in both 
FENO and sputum was very high, in particular, for those with 
previously diagnosed asthma, resulting in over two-thirds 
requiring optimization of medication and change of manage-
ment. These data suggest that better individualized clinical 
evaluation is required and a larger community-based study 
is needed to ascertain objective diagnoses in a setting of high 
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prevalence of chronic disease (e.g., bronchiectasis) to improve 
clinical outcomes particularly for Indigenous Australians. Our 
cohort study on children referred to respiratory specialists 
for chronic cough found that 70% were previously diagnosed 
incorrectly with asthma before referral (44). Also, Indigenous 
children were significantly more likely to have radiologically 
proven bronchiectasis (odds ratio = 4.4, 95% CI 1.9, 10) than 
non-Indigenous children on further evaluation. As respiratory 
issues account for the most common reason why Indigenous 
Australians present to doctors and the second most common 
self-reported chronic illness (45), it is imperative that better 
individualized management is required.
Our results are also consistent with national data describing 
91% of Australian youth with asthma reporting poor control, 
with 63% reporting being short of breath on a weekly basis (38). 
In addition, 11.6% reported being current smokers (38). Plausible 
factors for suboptimal management in this group may include 
independent decision making of adolescents, reduced role of 
caregivers, less medical supervision, decreased adherence to 
therapy, and peer pressure (46). Further, individuals from low 
socioeconomic backgrounds are at particular risk for poorer 
outcomes, as found by a recent study evaluating risk factors 
for asthma-related deaths in children (47). Earlier studies have 
shown that the proportion of Indigenous children with poorly 
controlled asthma is higher than Australia-wide data, and that 
management was generally suboptimal (48).
Our study has several limitations. Firstly, the numbers 
of students were lower than anticipated. We had planned to 
include 200 Grade 7 students; however, with the withdrawal 
of a large school shortly before commencing the ASPP, we had 
limited time to find another school, which was much smaller. 
Secondly, one school required parental consent for objective 
measurements (e.g., eCO test and questionnaires). Thirdly, the 
smoking pledge was inconsistently done with Peer Leaders in 
the fourth lesson of the program. Nevertheless, valuable lessons 
were learnt that will support future implementation of the ASPP 
include (i) while we received high level school support, earlier 
involvement with class teachers is needed to encourage support 
of Peer Leaders during lessons, (ii) negotiating opt-out consent 
will provide more robust data to further strengthen findings 
from previous studies (16, 17), and (iii) questionnaires were not 
suitable for this population and further modification is required 
to make them more literacy and language appropriate. Using 
electronic devices such as tablets to complete questionnaires 
will restrict the possibility of conflicting responses, in addition 
to having a more reliable dataset to compare against objective 
measurements such as eCO levels. It could be argued that the 
withdrawal of the third school meant that the ASPP program 
may not feasible in the NT. However, we do not believe this 
is the case and would not have impacted the outcomes of this 
feasibility pilot study for several reasons. First, we were plan-
ning to undertake the study in two schools only, however, when 
one school was unable participate in the study due to logistical 
reasons at the school level, which were not related to the study, 
we had to recruit another smaller school in the vicinity, which 
also had high proportions of Indigenous students. Second, we 
have shown the feasibility of the ASPP in two diverse schools 
in Darwin as discussed above. Importantly, the implementa-
tion of the program model has shown to be effective in other 
geographically diverse populations in rural and metropolitan 
regions in Australia and in Jordan (15, 17, 24).
In conclusion, implementation of the ASPP in two urban-based 
NT schools was feasible and well received by the NT Department 
of Education and Children’s Services and schools. Of the students 
reporting current respiratory symptoms, most were found to have 
clinically significant airway inflammation and suboptimal man-
agement. Therefore, better community-based data, improving 
asthma management and preventing uptake of tobacco smoking 
of adolescents through innovative programs such as the ASPP 
in schools could potentially improve lung health particularly of 
Indigenous Australians.
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